We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
(-2.3%)
Cap. Flow
-$358M
Cap. Flow
% of AUM
-9.89%
Top 10 Holdings %
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$254M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$46.3M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$30.5M |
| 4 |
VBIL
Vanguard 0-3 Month Treasury Bill ETF
VBIL
|
+$29.2M |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46.2M |
| 2 |
Microsoft
MSFT
|
+$46.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$40M |
| 4 |
NVIDIA
NVDA
|
+$27.6M |
| 5 |
Palantir
PLTR
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.33% |
| 2 | Financials | 7.48% |
| 3 | Consumer Discretionary | 6.48% |
| 4 | Healthcare | 6.28% |
| 5 | Communication Services | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMDA
3451
Omada Health Inc
OMDA
$1.44B
| $17K | ﹤0.01% |
768
+492
| +178% | +$10.1K |
|
|
OGI
3452
Organigram Holdings
OGI
$177M
| $17K | ﹤0.01% |
8,364
+7,530
| +903% | +$11.8K |
|
3453
Butterfly Network
BFLY
$2.36B
| $17K | ﹤0.01% |
8,791
-5,429
| -38% | -$9.22K |
|
3454
CAMP4 Therapeutics
CAMP
$284M
| $16.9K | ﹤0.01% |
5,649
+1,819
| +47% | +$3.37K |
|
3455
Personalis
PSNL
$1.54B
| $16.9K | ﹤0.01% |
2,598
-3,820
| -60% | -$21.7K |
|
3456
Biote Corp
BTMD
$40.7M
| $16.9K | ﹤0.01% |
5,643
-1,291
| -19% | -$4.61K |
|
3457
NerdWallet
NRDS
$617M
| $16.9K | ﹤0.01% |
1,572
-2,321
| -60% | -$24.7K |
|
3458
First Community Bankshares
FCBC
$927M
| $16.8K | ﹤0.01% |
484
-3,479
| -88% | -$132K |
|
3459
Inspired Entertainment
INSE
$163M
| $16.8K | ﹤0.01% |
1,794
-1,111
| -38% | -$10K |
|
3460
Anika Therapeutics
ANIK
$295M
| $16.8K | ﹤0.01% |
1,786
-163
| -8% | -$1.56K |
|
|
AUTL
3461
Autolus Therapeutics
AUTL
$564M
| $16.7K | ﹤0.01% |
10,268
+5,991
| +140% | +$11.7K |
|
3462
Ginkgo Bioworks
DNA
$486M
| $16.7K | ﹤0.01% |
1,145
-1,636
| -59% | -$19.6K |
|
3463
Surf Air Mobility
SRFM
$97.8M
| $16.7K | ﹤0.01% |
3,886
-15,123
| -80% | -$70.9K |
|
|
ZH
3464
Zhihu
ZH
$272M
| $16.7K | ﹤0.01% |
3,285
+2,885
| +721% | +$13.6K |
|
3465
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.61B
| $16.7K | ﹤0.01% |
+1,240
| New | +$16.4K |
|
3466
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$590M
| $16.6K | ﹤0.01% |
394
+388
| +6,467% | +$15.9K |
|
|
CWBC
3467
Community West Bancshares
CWBC
$706M
| $16.6K | ﹤0.01% |
797
-2,440
| -75% | -$50.2K |
|
3468
Hamilton Beach Brands
HBB
$443M
| $16.6K | ﹤0.01% |
1,155
-1,620
| -58% | -$25.3K |
|
|
KMTS
3469
Kestra Medical Technologies
KMTS
$1.64B
| $16.6K | ﹤0.01% |
698
+596
| +584% | +$10.7K |
|
3470
Ezcorp Inc
EZPW
$1.78B
| $16.6K | ﹤0.01% |
870
-257
| -23% | -$4.03K |
|
3471
Carter Bankshares
CARE
$749M
| $16.6K | ﹤0.01% |
853
-2,923
| -77% | -$54.5K |
|
|
ATXS
3472
DELISTED
Astria Therapeutics
ATXS
| $16.5K | ﹤0.01% |
2,270
-3,631
| -62% | -$24.6K |
|
|
CCRN
3473
DELISTED
Cross Country Healthcare
CCRN
| $16.5K | ﹤0.01% |
1,159
-2,427
| -68% | -$32.1K |
|
3474
Quanterix
QTRX
$139M
| $16.4K | ﹤0.01% |
3,028
-2,245
| -43% | -$11.9K |
|
|
JBIO
3475
Jade Biosciences
JBIO
$1.48B
| $16.4K | ﹤0.01% |
1,905
-1,184
| -38% | -$9.68K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review
As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.
- Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
- Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
- Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
- Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
- Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
- Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.